Spyre Therapeutics
SYRE
#5743
Rank
C$1.17 B
Marketcap
$19.58
Share price
-5.36%
Change (1 day)
-55.86%
Change (1 year)

EPS for Spyre Therapeutics (SYRE)

EPS in 2024 (TTM): -$96.12

According to Spyre Therapeutics's latest financial reports the company's current EPS (TTM) is -$100.00. In 2023 the company made an earnings per share (EPS) of -$68.05 a decrease over its 2022 EPS that were of -$34.29.

EPS history for Spyre Therapeutics from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-$96.1241.25%
2023-$68.0598.46%
2022-$34.29-1%
2021-$34.64-34.21%
2020-$52.65-37.96%
2019-$84.8615.02%
2018-$73.7718.33%
2017-$62.34-18.92%
2016-$76.89120.2%
2015-$34.92-33.55%
2014-$52.55